Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/40462
A DOUBT OF MULTIPLE INTRODUCTION OF SARS-COV-2 IN ITALY: A PRELIMINARY OVERVIEW
Affilliation
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Flavivírus. Rio de Janeiro, RJ, Brasil / Universidade Federal de Minas Gerais. Instituto de Ciências Biológicas. Belo Horizonte, MG, Brasil.
University Campus Bio-Medico of Rome. Unit of Clinical Laboratory Science. Rome, Italy.
University Campus Bio-Medico of Rome. Unit of Medical Statistics and Molecular Epidemiology. Rome, Italy.
University Campus Bio-Medico of Rome. Unit of Medical Statistics and Molecular Epidemiology. Rome, Italy.
University Campus Bio-Medico of Rome. Unit of Clinical Laboratory Science. Rome, Italy.
University Campus Bio-Medico of Rome. Unit of Medical Statistics and Molecular Epidemiology. Rome, Italy.
University Campus Bio-Medico of Rome. Unit of Medical Statistics and Molecular Epidemiology. Rome, Italy.
Abstract
The emergence of the novel beta Coronavirus, recently renamed as severe acute
respiratory syndrome coronavirus 2, SARS-CoV-2, has raised serious concerns due to
the virus rapid dissemination worldwide. Nevertheless, there is limited information
about the genomic epidemiology of SARS-CoV-2 circulating in Italy from surveillance
studies. The shortage of complete genomic sequences available impairs our
understanding of the SARS-CoV-2 introduction and establishment in the country. To
better understand its dynamics in Italy, we analysed complete genomes of SARS-CoV2 isolates, obtained directly from clinical samples. Our phylogenetic reconstructions
suggest possible multiple introduction of SARS-CoV-2. Continued genomic
surveillance strategies are needed to improve monitoring and understanding of the
currently SARS-CoV-2 epidemics, which might help to attenuate public health impact
of infectious diseases.
Share